Jul 28, 2017
The UK is entering into unchartered waters between Brexit – offering potentially new approaches to procurement – and negotiating a successor to the PPRS. The government's new recruit Steve Oldfield could give it the inside track, writes Leela Barham.
Jul 24, 2017
The era of complex biological drugs requires sales reps with more advanced knowledge, write Bagrat Lalayan.
Jul 21, 2017
The UK's proposed Accelerated Access Review is being dogged by delay and disappointment, writes Leela Barham.
Jul 18, 2017
The Association of the British Pharmaceutical Industry is seeking permission for a Judicial Review of NICE's affordability proposals. Leela Barham reports.
Jul 17, 2017
Pharmaceutical Executive
While it’s easy to get excited about new gadgets, remember that the overall goal of mHealth and social media must be to deepen relationships and communication.
Jul 14, 2017
With the US Institute for Clinical and Economic Review (ICER) looking like it is here to stay, Leela Barham reviews its value framework.
Jul 13, 2017
In the second of her articles on value assessment, Leela Barham discusses the emergence of multiple frameworks in the US and considers their impact.
Jul 11, 2017
Maiko Midena discusses the key fundamentals to success when it comes to forecasting with large multinational pharmaceutical organizations.
Jul 10, 2017
Just as internal company compliance regulation needs to change, so too does compliance education, writes Dr. Nick Broughton.
Jul 07, 2017
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Three messages that resonated from this year’s annual meeting of the Drug Information Association.
lorem ipsum